COVID-19

South Australians Wanted For COVID-19 Vaccine Trial

Researchers are seeking around 100 healthy Adelaide-based adults who would be interested in joining the first phase of the vaccine trial that potentially will go ahead later this year.

Researchers from PARC Clinical Research at the Royal Adelaide Hospital are seeking volunteers to screen for a potential COVID-19 vaccine trial to see if a vaccine can help prevent the potentially deadly illness.

Royal Adelaide Hospital Clinical immunologist, Dr Pravin Hissaria, said people over the age of 18 are encouraged to apply for a possible upcoming trial which could potentially result in an historic medical breakthrough.

“COVID-19 has had a devastating impact on the world and that is unlikely to change until we can find a permanent solution,” Dr Hissaria said.

“A number of vaccines are showing promising results in animal models so we are excited at the prospect of beginning human trials in Adelaide, and include others in this exciting journey.”

Researchers are seeking around 100 healthy Adelaide-based adults who would be interested in joining the first phase of the vaccine trial that potentially will go ahead later this year.

Potential participants will need to undergo a 45 minute screening session to assess their suitability which would include a review of their medical history and a blood test.

PARC Clinical Research’s Professor Guy Ludbrook, said the early screening process will commence shortly in order to allow the trial to begin straight away, once the trial is confirmed and the vaccine is available. in the coming months.

“We want South Australia to lead the way on the development of a COVID-19 vaccine, so we would encourage anyone looking to play a part, to put their hand up and get involved,” Professor Ludbrook said.

“By commencing the initial screening process now, we will be able to get started on the trial without any delay as soon it has been finalised,

“Your involvement may result in success of medical research to find a vaccine for this global pandemic.”

The potential trial would run for a period of 6 to 9 months. Details for the trial are still being worked through, and further information is expected to be available in coming weeks.

For more information about participating in the screening, call PARC Clinical Research at the Royal Adelaide Hospital on 08 7074 2996.

More News

To Top